Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CH Melatonin receptor agonists
N05CH02 Ramelteon
D02689 Ramelteon (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Sleep Disorder Agents
Sleep Promoting Agents
Melatonin Receptor Agonists
Ramelteon
D02689 Ramelteon (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D02689 Ramelteon (JAN/USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01589 Melatonin receptor agonist
D02689 Ramelteon
DG03202 Hypnotic
D02689 Ramelteon
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D02689 Ramelteon
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03202 Hypnotic
D02689 Ramelteon
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Melatonin
MTNR1
D02689 Ramelteon (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02689
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02689
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02689
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02689